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ABSTRACT
Objective: Laparoscopy is increasingly being used as
an alternative to open surgery in the treatment of
patients with colon cancer. The study objective is to
estimate the difference in hospital costs between
laparoscopic and open colon cancer surgery.
Design: Population-based retrospective cohort study.
Settings: All acute hospitals of the National Health
System in England.
Population: A total of 55 358 patients aged 30 and
over with a primary diagnosis of colon cancer admitted
for planned (elective) open or laparoscopic major
resection between April 2006 and March 2013.
Primary outcomes: Inpatient hospital costs during
index admission and after 30 and 90 days following
the index admission.
Results: Propensity score matching was used to
create comparable exposed and control groups. The
hospital cost of an index admission was estimated to
be £1933 (95% CI 1834 to 2027; p<0.01) lower
among patients who underwent laparoscopic resection.
After including the first unplanned readmission
following index admission, laparoscopy was £2107
(95% CI 2000 to 2215; p<0.01) less expensive at
30 days and £2202 (95% CI 2092 to 2316; p<0.01)
less expensive at 90 days. The difference in cost was
explained by shorter hospital stay and lower
readmission rates in patients undergoing minimal
access surgery. The use of laparoscopic colon cancer
surgery increased 4-fold between 2006 and 2012
resulting in a total cost saving in excess of £29.3
million for the National Health Service (NHS).
Conclusions: Laparoscopy is associated with lower
hospital costs than open surgery in elective patients
with colon cancer suitable for both interventions.
INTRODUCTION
The introduction of laparoscopic surgery has
resulted in signiﬁcant improvements in out-
comes for a range of surgical procedures
including colon cancer resection. A number
of studies show that laparoscopic colon
cancer surgery is associated with better
outcomes compared with open surgery both
in terms of reduced mortality rates1 2 and
other secondary outcomes such as shorter
length of stay, reduced surgical complica-
tions, and reduced bleeding and pain.3–8
Laparoscopy has been increasingly used as
an alternative to open resection for patients
with colon cancer in England9 10 as well as
in other countries.11 12 In England, the
uptake of laparoscopy has been facilitated by
increasing evidence of improved outcomes,
effective training of surgeons in performing
the procedure10 13 and the endorsement by
the National Institute for Health and Care
Excellence (NICE) of laparoscopy as an
oncologically acceptable alternative to open
surgery.14
Evidence on the difference in the hospital
costs of laparoscopy in comparison to open
surgery is still limited. In England, the most
recent Health Technology Assessment (HTA)
study15 concluded that the hospital cost of
a laparoscopic surgery was £265 (95% CI –
3829 to 4405) greater than an open proced-
ure in colorectal patients. However, this
difference is not statistically signiﬁcant and
the authors recognise that evidence on costs
was limited and based on heterogeneous
Strengths and limitations of this study
▪ Large study population including all patients with
colon cancer undergoing an elective colectomy
in National Health Service (NHS) hospitals in
England between 2006 and 2012.
▪ Large administrative data set on costs reported
by all NHS hospitals in England.
▪ Our analysis is unable to provide direct control
for some patient characteristics, such as cancer
staging, obesity and the use of stomas. We
provide indirect control for these factors by
using propensity score matching and sensitivity
analyses on restricted subsamples of low-risk
patients.
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studies. Similar evidence is found in a short-term cost
analysis from the CLASICC randomised controlled trial
(RCT): the difference was £268 (95% CI –689 to 1457)
for a laparoscopic procedure and not statistically signiﬁ-
cant.16 Theatre costs were found to be higher for lapar-
oscopy, while other hospital costs such as ward, hospital
stay and complications were higher in the patients ran-
domised to the open procedure.
The objective of this study is to produce new evidence
on the difference in hospital costs between laparoscopic
and open resections in patients with colon cancer. We
use retrospective data on the whole population of
patients with colon cancer undergoing an elective
surgery between April 2006 and March 2013 in National
Health Service (NHS) hospitals in England. By examin-
ing a large population of patients, our analysis aims to
reduce the problem of heterogeneity that might have
affected estimates from previous studies. The HTA and a
recent systematic literature review highlighted that het-
erogeneity in the examined studies affected the general-
isability of the results of the meta-analysis of hospital
costs.15 17
Finally, most of the existing evidence for England are
based on patients admitted between 1996 and 2004
when only a restricted number of surgeons had experi-
ence in performing laparoscopic resections. In recent
years, laparoscopic interventions have become more
established technologies and account for more than half
of all the elective surgery procedures performed on
patients with colon cancer. The diffusion of laparoscopy
is likely to have had an impact on costs as an increasing
number of surgeons achieve greater experience in per-
forming the new procedure thereby reducing operating
time, patient length of stay and conversion rates.18
Therefore, new evidence on costs is needed to inform
surgeons and hospital managers on the most efﬁcient
intervention and to support the efﬁcient allocation of
healthcare resources.
METHODS
Data sources
Anonymised patient-level records were extracted from
the Hospital Episode Statistics (HES) database.i HES is a
hospital administrative database which routinely collects
information on all admissions to NHS hospitals and a
minority of private hospitals in England and has been
described in detail elsewhere.19 Data are collected at the
level of a consultant episode, that is, the time the
patient spends under the care of a single consultant
team. Data ﬁelds include patient primary diagnosis and
comorbidities (up to 20 comorbidities), which are
coded using the International Classiﬁcation of Disease
10th revision (ICD-10), and medical treatments and
procedures (up to 24 procedures are coded) which are
coded using the Ofﬁce of Population Censuses and
Surveys Classiﬁcation of Surgical Operations and
Procedures 4th revision (OPCS-4).20 Information on
admission and discharge dates, health outcome at dis-
charge and whether the admission was planned (elect-
ive), or unplanned (emergency), is also included in
HES. A range of pertinent sociodemographic informa-
tion is also available, including age, sex and deprivation
score of area of residence.
Hospital admission costs were obtained from the
National Schedule of Reference Costs (NSRC) 2012/
2013. NHS hospitals are mandated to report the unit
cost of each of the services delivered to their patients
every year. To this end, medical treatment and proce-
dures delivered during a consultant episode are
grouped into homogeneous Healthcare Resource
Groups (HRGs) and costs are apportioned following
guidelines produced by Public Health England.21
Hospitals report the average cost of regular length of
stay patients and the extra cost of outlier length of stay
patients for each HRG and type of admission. They also
report the total number of bed days and consultant epi-
sodes by HRG and type of admission. Cost information
on 2353 different HRGs is reported in the NSRC 2012/
2013 and we matched these data to each year of HES
data using the procedure described in the Costs section
below.
This study followed Strengthening of Reporting
Observational Studies in Epidemiology (STROBE)
guidelines.22
Patients
All patients aged 30 years and over who underwent elect-
ive colonic resection with a diagnosis of colon cancer
(ICD-10 diagnosis ‘C18’) between April 2006 and March
2013 were included in the analysis, where the index
admission length of stay did not exceed 90 days. We
excluded admissions occurring 12 months after the ﬁrst
admission, that is, the index admission. The following
OPCS codes were used to identify open procedures:
H05/H29 (subtotal/total colectomy), H06 (extended
right hemicolectomy), H07 (right hemicolectomy),
H08 (transverse colectomy), H09 (left hemicolectomy),
H10 (sigmoid colectomy) and H11 (other colectomy).
A procedure was considered to be laparoscopic in the
presence of any of the following additional codes: Y50.8,
Y75.1 and Y75.2. Also, laparoscopic procedures con-
verted to open were included in this group (Y71.4 and
Y71.8).
Costs
We used the hospital cost of each patient admission as
the outcome variable in our analysis with costs estimated
at 2012 prices. We obtained this variable by combining
information reported in HES on patient admissions and
information reported in the NSRC on HRG costs. The
cost variable was calculated as follows:
iCopyright 2014, used with the permission of the Health & Social Care
Information Centre. All rights reserved.
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First, we calculated the national average cost for each
HRG as a weighted average of the HRG costs reported
by every hospital. This reduced the scope for hospital
errors in reporting the cost of their services. Second, we
calculated the cost per bed day by using information
reported on total activity and total bed days for each
HRG and calculated these separately for regular and for
outlier length of stay. Third, we matched the HRG bed
day cost obtained from the NSRC to the corresponding
HRG reported in HES. We used the patient length of
stay reported in HES to construct our estimate of the
admission cost for each patient in our sample as follows:
Patient cost ¼½bedday cost ðNSRCÞ
 length of stay ðHESÞhrgðregular stayÞ
þ ½bedday cost ðNSRCÞ
 length of stay ðHESÞhrgðoutlier stayÞ
ð1Þ
This method of costing inpatient care has been used pre-
viously.23–25 In the absence of a separate HRG for laparo-
scopic and open colectomy, the difference in theatre
costs associated with the two procedures was estimated
using a weighted average of the difference reported by
two most recent RCTs on patients with colon cancer.16 26
The additional operating cost for laparoscopy amounted
to £532 at 2012 prices.
Outcome measures
The primary outcome measure of this study was the hos-
pital cost of laparoscopic versus open colectomy.
Hospital costs were calculated for the initial admission
and for the ﬁrst of any unplanned readmissions occurring
within 30 and 90 days after discharge. Secondary out-
comes were 30-day in-hospital mortality and unplanned
readmission rates at 30 and 90 days after discharge.
Laparoscopy rates and costs were also compared by
operation subtype as part of the sensitivity analyses.
Statistical methods
Statistical analysis was undertaken using STATA V.13
(StataCorp LP, College Station, Texas, USA). The χ2 tests
were used to compare categorical variables. The esti-
mates of the differences in cost between laparoscopic
and open surgery were calculated using propensity score
matching (PSM) of patient, area of residence and hos-
pital characteristics. PSM allows us to generate a control
group of open resection patients who are similar to
patients undergoing a laparoscopic operation. PSM
allows for any differences between the open and laparo-
scopic groups to be reduced by matching on the pro-
pensity score calculated from patient, area of residence
and hospital characteristics. The potential confounders
used to match patients were age, Charlson comorbidity
index score, number of diagnoses, deprivation index (in
quintiles) and year of procedure. In order to control for
differences in the characteristics of the healthcare provi-
ders, ﬁxed effects for the hospitals of patients’ admission
were included in the matching. A match of the 10 closest
patients (neighbours) was undertaken. To prevent poor
matches, a caliper was used which included only matched
patients within 0.25 SDs of each other.27 PSM was under-
taken on 20 238 who had a laparoscopic resection
(exposed group) and 33 750 (unexposed group).
Ethics statement
We used fully anonymised and unidentiﬁable hospital
administrative data from HES database.
RESULTS
Descriptive statistics
In total, 55 358 elective colorectal resections were ana-
lysed over the 7-year study period. Table 1 compares the
characteristics of patients who underwent laparoscopic
and open surgery in the study sample. The laparoscopy
group had a slightly lower proportion of patients with
high Charlson scores and fewer diagnoses (p<0.01). Such
differences noticeably reduce and are not statistically sig-
niﬁcant in the matched sample as shown in table 1.
Trends over time
Figure 1 presents the proportion of colon cancer opera-
tions undertaken by the laparoscopic or open approach
between April 2006 and March 2013. In 2006, only
13.1% of colectomies were laparoscopic. Over the next
7 years, a sharp increase in laparoscopic rates was
observed. By 2012, 54.5% of patients in our study sample
underwent laparoscopic colectomy. Trends in the use of
laparoscopy across hospitals also changed over time (see
online supplementary appendix ﬁgure A1).
Primary outcomes
Table 2 presents the unadjusted and adjusted differences
in hospital costs and mean length of stay between lap-
aroscopic and open resections in our study sample.
Unadjusted comparisons show large differences in hos-
pital costs and length of stay due to differences in the
characteristics of the patients undergoing the two treat-
ments. PSM allows us to adjust for these differences and
remove their confounding effect on the examined
outcomes.
After adjusting, the cost of a patient undergoing lap-
aroscopic surgery was £1933 (95% CI 1744 to 2122,
p<0.01) less at the index admission. With the inclusion
of costs of ﬁrst readmission at 30 and 90 days following
initial discharge, this saving rose to £2107 (95% CI 1896
to 2315, p<0.01) and £2202 (95% CI 1982 to 2420,
p<0.01), respectively. Length of stay was 2.5 days (95%
CI 2.3 to 2.7, p<0.01) shorter for patients following
laparoscopic surgery.
ORs from the logistic analyses are given in online
supplementary appendix table A1. A ﬁgure illustrating
the performance of PSM between the laparoscopy and
open groups is given in online supplementary appendix
ﬁgure A2.
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Comparison of adjusted mortality and readmission rates
Table 3 gives the adjusted rates and ORs following
PSM analysis for mortality and readmission.
Laparoscopy was associated with a signiﬁcantly lower
mortality within 30 days of admission (OR 0.60, 95%
CI 0.46 to 0.75, p<0.01). There was also a signiﬁcantly
lower rate of readmission both within 30 days (OR
0.87, 95% CI 0.77 to 0.96, p<0.01) and 90 days (OR
0.85, 95% CI 0.77 to 0.93, p<0.01) of discharge, com-
pared with open surgery.
Cost to the NHS
Table 4 reports the annual total hospital cost of colon
cancer resections in our study sample, including costs
incurred from ﬁrst unplanned readmission within
90 days of initial discharge. The third column reports
total costs using the observed rate of laparoscopic proce-
dures for the year studied, while the fourth column
reports an estimate of the total cost had the rate of
laparoscopy remained unchanged at 2006 levels.
Between 2006 and 2012, the change in surgical practice
Table 1 Characteristics of patients with colon cancer undergoing elective laparoscopic and open resections, 2006–2012
Before PS matching After PS matching
Laparoscopy Open Laparoscopy Open
Per cent Per cent p Value Per cent Per cent p Value
Age
30–40 1.1 1.1 <0.01 1.0 0.9 0.41
41–50 3.2 3.6 3.3 3.3
51–60 10.5 10.5 10.5 10.4
61–70 29.7 26.6 29.7 29.5
71–80 35.8 36.6 35.8 35.9
81+ 20.7 21.6 19.7 20.0
Weighted Charlson score
2 57.5 51.8 <0.01 56.5 56.9 0.92
3–4 24.7 24.6 24.9 24.3
5+ 17.8 23.6 18.6 18.8
Number of diagnoses
1–2 25.1 24.5 <0.01 25.1 25.3 0.56
3–4 30.9 30.2 31.0 30.6
5–6 22.2 22.3 22.2 22.0
7+ 21.8 23.0 21.7 22.1
Deprivation score
Least deprived 18.5 20.9 <0.01 18.6 18.5 0.30
2 19.8 20.1 19.8 19.4
3 19.8 20.1 19.9 19.7
4 20.5 19.7 20.4 20.6
Most deprived 21.4 19.2 21.3 21.8
Female 47.7 48.3 <0.21 47.7 47.9 0.60
PS, propensity matching.
Figure 1 Shares of laparoscopic
and open resections in patients
with colon cancer undergoing
elective surgery, 2006–2012.
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that favoured the increasing use of laparoscopic surgery
resulted in an estimated cost saving of £29.3 million for
the NHS hospitals.
Sensitivity analyses
Among both laparoscopic and open surgery groups, the
distribution in operation subtypes was broadly similar.
The most common procedure in each group was ex-
tended right/right hemicolectomy followed by sigmoid
colectomy (see online supplementary appendix table
A2). Procedure subtypes were not included in the list of
matching variables as they may not affect the allocation
of patients to a laparoscopic or open intervention, and
can be considered as part of the intervention.
Cost savings during the initial admission and ﬁrst
unplanned readmission within 90 days were found in all
types of colectomy (see online supplementary appendix
table A3). The greatest difference was observed for
sigmoid colectomy (H10) where laparoscopy was asso-
ciated with a saving of £2285 (95% CI 1800 to 2771,
p<0.01).
Subanalysis of a restricted sample of patients with a
length of stay of <30 days, and no more than a single
consultant episode (see online supplementary appendix
table A4). PSM analysis in this group of 47 483 patients
showed smaller but still noticeable differences. After
matching, the cost saving of laparoscopic surgery was
£1593 (95% CI 1477 to 1709, p<0.01) compared with
open surgery; the difference was £1737 (95% CI 1604 to
1871, p<0.01) with the inclusion of 30-day readmission
costs and £1831 (95% CI 1604 to 1871, p<0.01) with
90-day readmission costs.
Subanalysis using 2012–2013 data only was also under-
taken in order to reduce potential selection bias from
early adopters that might have selected easier cases
in early years (see online supplementary appendix
table A5). Estimated differences in adjusted costs
between the two procedures were very similar to those
found in the main analysis.
DISCUSSION
This study produces new evidence on the difference in
hospital costs between elective laparoscopic and open
resections in patients with colon cancer. We used retro-
spective data on the whole population of patients under-
going an elective surgery in NHS hospitals in England
from April 2006 to March 2013. PSM was used to create
two similar groups of patients undergoing the two treat-
ments. We ﬁnd evidence that laparoscopic surgery is the
less expensive treatment and can result in savings of
£1933 in hospital costs during the ﬁrst admission or
£2202 if including unplanned readmissions occurring
within 90 days of discharge. Although laparoscopic
surgery requires initial investments in equipment and
training, these costs are more than compensated by
savings from reduced hospital length of stay and
reduced risk of readmissions.
Our study also supports evidence from previous
studies that patients undergoing laparoscopic surgery
have reduced mortality and readmission rates compared
with open surgery.1 2 5 6 9 28 29
Our results are in line with recent evidence from inter-
national studies showing laparoscopy to be a less costly
Table 2 Differences in hospital costs between laparoscopic and open resections in patients with colon cancer undergoing
elective surgery, 2006–2012
Unadjusted outcomes
Open Laparoscopy Difference
Cost of initial admission £11 727 £9215 £2512
Including 30-day readmission £12 311 £9604 £2707
Including 90-day readmission £12 581 £9761 £2820
Length of stay 11.9 days 8.5 days 3.4 days
Adjusted outcomes
Open Laparoscopy Difference 95% CI p Value
Cost of initial admission £11 145 £9214 £1933 £1744 to £2122 <0.01
Including 30-day readmission £11 710 £9603 £2107 £1896 to £2315 <0.01
Including 90-day readmission £11 964 £9762 £2202 £1982 to £2420 <0.01
Length of stay 11.0 days 8.5 days 2.5 days 2.3–2.7 days <0.01
Table 3 Risk-adjusted mortality and hospital readmissions following laparoscopic and open resections in patients with colon
cancer undergoing elective surgery, 2006–2012
Open (%) Laparoscopy (%) OR 95% CI p Value
30-day in-hospital mortality 2.0 1.2 0.60 0.46 to 0.75 <0.01
30-day unplanned readmission 4.8 4.2 0.87 0.77 to 0.96 <0.01
90-day unplanned readmission 6.9 5.9 0.85 0.77 to 0.93 <0.01
Laudicella M, et al. BMJ Open 2016;6:e012977. doi:10.1136/bmjopen-2016-012977 5
Open Access
approach for patients with colon and colorectal cancer.
Studies from Ireland, Canada and Australia have
reported cost savings of €4591 (∼£3600),30 $3121
(∼£2062)31 and €2012 (∼£1578),32 respectively. These
studies found that shorter hospital stay and lower post-
operative costs were the major contributors to cost
savings which offset the larger operative costs associated
with laparoscopy when compared with open surgery.
Finally, a recent study from the USA found similar evi-
dence in patients without cancer undergoing a colec-
tomy.33 In our PSM analysis, we ﬁnd a shorter length of
stay of 2.5 days for laparoscopic patients. A similar differ-
ence is reported in a number of RCTs.3 4 6 16 26
In England, the most recent evidence on costs comes
from the 2006 HTA15 and the CLASICC trial16 and it is
based on patients admitted between 1996 and 2004. Both
studies report a small and non-statistically signiﬁcant
difference in hospital costs with large CIs; laparoscopy
was the more expensive procedure with a difference of
£265 (95% CI −3829 to 4405) in the former and £268
(95% CI −689 to 1457) in the latter. Heterogeneity in
the study sample might explain the large CIs in the
results of the cost analysis in the HTA and in a recent sys-
tematic literature review.12 Signiﬁcant heterogeneity was
found for operative time, intraoperative blood loss, dur-
ation of hospital length of stay, overall postoperative com-
plications and cost of surgery in the short-term analysis.
Moreover, the laparoscopic resection was a less common
procedure at the time of the HTA and CLASICC trial
and signiﬁcant progress in performing this intervention
are likely to have occurred in recent years as laparoscopy
has become as prevalent as open surgery.
Study limitations
This study is based on a retrospective analysis of adminis-
trative data from HES. The study design does not allow
us to control for a number of factors that are likely
to inﬂuence patients’ allocation to a laparoscopic or
open intervention and potentially result in selection
bias. The HES data do not include information on some
patient characteristics that might make them unﬁt for
laparoscopic surgery, such as obesity and multiple
previous abdominal operations. The use of stomas has
also not been factored into the analysis, which may inﬂu-
ence length of stay and readmission rates. Finally, cancer
staging is not reported and we are unable to stratify for
this variable in our analysis. Larger or more advanced
tumours may be selected for open surgery over laparos-
copy and these may be associated with more extensive
procedures with increased postoperative complications
and costs.9 We use a number of techniques to mitigate
potential selection bias from unreported patients’
characteristics.
First, our analysis is restricted to elective admissions
only as emergency presentation is more likely to
capture advanced tumours in a screened population.
A similar approach has been used in a number of
earlier studies using HES data to compare the out-
comes of laparoscopy and open resections in patients
with colon cancer.2 7 9 10 20 29
Second, our study examines the difference in costs
between the two procedures in 2006–2012 when laparos-
copy reached a similar level of diffusion as open surgery
reducing the scope for selection bias from early adop-
ters. We use PSM techniques to create a similar sample
of patients undergoing the two treatments in a large
population of patients with colon cancer. Although PSM
cannot assure the same level of randomisation as an
RCT, the issue of patient selection should be less rele-
vant in our study population as the prevalence of lapar-
oscopy is similar to open resection in the examined
years. PSM allows us to analyse retrospective data on a
very large population of patients reducing the problem
of heterogeneity and increasing the power of the statis-
tical analysis and external validity of results. Finally, we
are able to produce robust evidence at a fraction of the
cost of an RCT.
Third, we conducted a number of sensitivity analyses
to test the robustness of our ﬁndings to potential sample
selection bias. We examined a highly restricted sample
of patients who had routine and uncomplicated elective
admissions, and who are less likely to be frail and having
comorbidities; differences in outcomes and cost savings
are still present. We also repeated our analysis using
Table 4 Estimated cost savings for colon cancer surgery (including 90-day unplanned readmission costs) due to the rise in
laparoscopy rates since 2006
Year Laparoscopy rate
Costs: actual
laparoscopy rate
Costs: fixed 2006
laparoscopy rate
Achieved
savings
(£ millions) (£ millions) (£ millions)
2006 13.1% 84.3 84.3 0.0
2007 21.5% 86.5 87.8 1.3
2008 32.6% 89.5 92.9 3.4
2009 39.6% 89.1 93.8 4.7
2010 44.9% 89.4 95.1 5.7
2011 50.3% 91.3 98.2 6.9
2012 54.5% 86.7 94.0 7.3
2006–2012 − 616.8 646.1 29.3
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2012–2013 data only in order to reduce the scope for
selection bias from early adopters who are likely to
select easier cases as the prevalence of laparoscopic
surgery moves from 13.1% in 2006–2007 to 54.5% in
2012–2013. We ﬁnd very similar results suggesting that
the differences in costs and outcomes are explained by
laparoscopic surgery rather than selection bias from
early adopters.
This study combines retrospective data on hospital
admissions from HES with data on service costs from the
NSRC creating a powerful tool of analysis. The validity
of these data for cost analysis has been demonstrated
elsewhere34 and the data have been successfully applied
in a number of empirical investigations on the costs of
care.23–25 However, NSRC data do not report the differ-
ence in theatre costs associated with the two procedures,
which was estimated using a weighted average of the dif-
ference reported by two most recent RCTs on patients
with colon cancer.16 26
Finally, this study focuses on direct hospital costs and
does not consider the opportunity costs associated with
the two interventions. On one hand, open resections are
associated with shorter operating theatre time, which
might offer the opportunity of performing more inter-
ventions per day. On the other hand, laparoscopic resec-
tions are associated with shorter postoperative length of
stay and lower probability of a 90 days readmission,
which might free up hospital beds and resources for
treating other patients. Assessing opportunity costs is
challenging as theatre time and hospital beds can be
allocated to a number of alternative uses depending on
the local demand for care and the local organisation of
health services.
CONCLUSION
This study supports the adoption of laparoscopic surgery
as a cost saving alternative to open surgery in patients
with colon cancer suitable for both interventions. The
adoption of laparoscopic surgery can lead to reduced
hospital stay, morbidity and mortality in the treatment of
colon cancer, which translate into cost savings for the
health system.
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